Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23211 | 354 | 20.8 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
1274 | 2 | MICRONEEDLES//TRANSDERMAL DRUG DELIVERY//TRANSDERMAL | 8757 |
23211 | 1 | SKIN BLANCHING//HUMAN SKIN BLANCHING ASSAY//ENHANCER CELL | 354 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SKIN BLANCHING | authKW | 422657 | 2% | 70% | 7 |
2 | HUMAN SKIN BLANCHING ASSAY | authKW | 359404 | 1% | 83% | 5 |
3 | ENHANCER CELL | authKW | 258772 | 1% | 100% | 3 |
4 | TOPICAL DRUG PRODUCT | authKW | 258772 | 1% | 100% | 3 |
5 | VERTICAL DIFFUSION CELL | authKW | 197156 | 1% | 57% | 4 |
6 | VASOCONSTRICTOR ASSAY | authKW | 196034 | 1% | 45% | 5 |
7 | SKIN BLANCHING ASSAY | authKW | 194078 | 1% | 75% | 3 |
8 | DERMATOLOGIC PRODUCT | authKW | 172515 | 1% | 100% | 2 |
9 | SUPAC SS | authKW | 172515 | 1% | 100% | 2 |
10 | TOPICAL DRUG CLASSIFICATION SYSTEM | authKW | 172515 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 4366 | 27% | 0% | 95 |
2 | Pharmacology & Pharmacy | 4201 | 63% | 0% | 222 |
3 | Chemistry, Medicinal | 567 | 12% | 0% | 44 |
4 | Chemistry, Multidisciplinary | 117 | 14% | 0% | 51 |
5 | Allergy | 14 | 1% | 0% | 4 |
6 | CYTOLOGY & HISTOLOGY | 10 | 0% | 0% | 1 |
7 | Medicine, Legal | 6 | 1% | 0% | 2 |
8 | Medicine, General & Internal | 3 | 3% | 0% | 11 |
9 | Medicine, Research & Experimental | 2 | 2% | 0% | 8 |
10 | Education, Scientific Disciplines | 0 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACEUT PHYS INFORMAT | 119424 | 2% | 23% | 6 |
2 | DOWNIE METAB UNIT | 86257 | 0% | 100% | 1 |
3 | KYOTO RD DRUG DEV S | 86257 | 0% | 100% | 1 |
4 | OFF STANDOFF GENER DRUGS | 86257 | 0% | 100% | 1 |
5 | OPSOFF PHARMACEUT SCI | 86257 | 0% | 100% | 1 |
6 | OTR OPQ | 86257 | 0% | 100% | 1 |
7 | OTS CDER FDA | 86257 | 0% | 100% | 1 |
8 | OWL PHARM | 86257 | 0% | 100% | 1 |
9 | PHARAMACODYNAM BIOPHARM | 86257 | 0% | 100% | 1 |
10 | PMR REHABIL SCI TECHNOL | 86257 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DISSOLUTION TECHNOLOGIES | 15136 | 2% | 3% | 6 |
2 | FARMACIA | 9672 | 3% | 1% | 10 |
3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 8704 | 11% | 0% | 40 |
4 | JOURNAL OF CLINICAL AND HOSPITAL PHARMACY | 5491 | 1% | 2% | 4 |
5 | SKIN PHARMACOLOGY | 4818 | 1% | 1% | 4 |
6 | JOURNAL DE PHARMACIE DE BELGIQUE | 3902 | 1% | 1% | 4 |
7 | CLINICAL TRIALS JOURNAL | 3880 | 1% | 1% | 4 |
8 | AAPS JOURNAL | 3726 | 2% | 1% | 7 |
9 | CURRENT PROBLEMS IN DERMATOLOGY | 3448 | 0% | 4% | 1 |
10 | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | 3083 | 2% | 1% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SKIN BLANCHING | 422657 | 2% | 70% | 7 | Search SKIN+BLANCHING | Search SKIN+BLANCHING |
2 | HUMAN SKIN BLANCHING ASSAY | 359404 | 1% | 83% | 5 | Search HUMAN+SKIN+BLANCHING+ASSAY | Search HUMAN+SKIN+BLANCHING+ASSAY |
3 | ENHANCER CELL | 258772 | 1% | 100% | 3 | Search ENHANCER+CELL | Search ENHANCER+CELL |
4 | TOPICAL DRUG PRODUCT | 258772 | 1% | 100% | 3 | Search TOPICAL+DRUG+PRODUCT | Search TOPICAL+DRUG+PRODUCT |
5 | VERTICAL DIFFUSION CELL | 197156 | 1% | 57% | 4 | Search VERTICAL+DIFFUSION+CELL | Search VERTICAL+DIFFUSION+CELL |
6 | VASOCONSTRICTOR ASSAY | 196034 | 1% | 45% | 5 | Search VASOCONSTRICTOR+ASSAY | Search VASOCONSTRICTOR+ASSAY |
7 | SKIN BLANCHING ASSAY | 194078 | 1% | 75% | 3 | Search SKIN+BLANCHING+ASSAY | Search SKIN+BLANCHING+ASSAY |
8 | DERMATOLOGIC PRODUCT | 172515 | 1% | 100% | 2 | Search DERMATOLOGIC+PRODUCT | Search DERMATOLOGIC+PRODUCT |
9 | SUPAC SS | 172515 | 1% | 100% | 2 | Search SUPAC+SS | Search SUPAC+SS |
10 | TOPICAL DRUG CLASSIFICATION SYSTEM | 172515 | 1% | 100% | 2 | Search TOPICAL+DRUG+CLASSIFICATION+SYSTEM | Search TOPICAL+DRUG+CLASSIFICATION+SYSTEM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SUGIYAMA, I , TAKAHASHI, N , SADZUKA, Y , (2016) EFFECT OF MIXING TIME AND STORAGE CONDITION ON CHARACTERIZATION OF HEPARINOID ADMIXTURES WITH CORTICOSTEROIDS.YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. VOL. 136. ISSUE 10. P. 1391 -1400 | 10 | 100% | 0 |
2 | SHAH, VP , RADULESCU, FS , MIRON, DS , YACOBI, A , (2016) COMMONALITY BETWEEN BCS AND TCS.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 509. ISSUE 1-2. P. 35 -40 | 13 | 76% | 0 |
3 | SOARES, KCC , MORAES, MV , GELFUSO, GM , GRATIERI, T , (2015) BIOEQUIVALENCE OF DERMATOLOGICAL TOPICAL MEDICINES: THE BRAZILIAN SCENARIO AND THE CHALLENGES FOR HEALTH SURVEILLANCE.CIENCIA & SAUDE COLETIVA. VOL. 20. ISSUE 11. P. 3599 -3608 | 10 | 91% | 0 |
4 | SMIT, P , NEUMANN, HAM , THIO, HB , (2012) THE SKIN-BLANCHING ASSAY.JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. VOL. 26. ISSUE 10. P. 1197 -1202 | 27 | 35% | 1 |
5 | OLEJNIK, A , GOSCIANSKA, J , NOWAK, I , (2012) ACTIVE COMPOUNDS RELEASE FROM SEMISOLID DOSAGE FORMS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 101. ISSUE 11. P. 4032 -4045 | 25 | 35% | 12 |
6 | TSAI, JC , CHENG, CL , TSAI, YF , SHEU, HM , CHOU, CH , (2004) EVALUATION OF IN VIVO BIOEQUIVALENCE METHODOLOGY FOR TOPICAL CLOBETASOL 17-PROPIONATE BASED ON PHARMACODYNAMIC MODELING USING CHINESE SKIN.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 93. ISSUE 1. P. 207-217 | 14 | 78% | 6 |
7 | SHAH, VP , YACOBI, A , RADULESCU, FS , MIRON, DS , LANE, ME , (2015) A SCIENCE BASED APPROACH TO TOPICAL DRUG CLASSIFICATION SYSTEM (TCS).INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 491. ISSUE 1-2. P. 21 -25 | 8 | 100% | 1 |
8 | SMITH, EW , HAIGH, JM , SURBER, C , (2002) QUANTIFICATION OF CORTICOSTEROID-INDUCED SKIN VASOCONSTRICTION: VISUAL RANKING, CHROMAMETER MEASUREMENT OR DIGITAL IMAGING ANALYSIS.DERMATOLOGY. VOL. 205. ISSUE 1. P. 3-10 | 12 | 92% | 11 |
9 | LEOPOLD, CS , (2003) PHARMACOKINETIC ANALYSIS OF THE FDA GUIDANCE FOR INDUSTRY 'TOPICAL DERMATOLOGIC CORTICOSTEROIDS: IN VIVO BIOEQUIVALENCE'.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 56. ISSUE 1. P. 53 -58 | 13 | 72% | 4 |
10 | LUONG, MS , LUONG, MP , LOK, C , CARMI, E , CHABY, C , VISEUX, V , (2000) BIOAVAILABILITY EVALUATION OF DERMOCORTICOIDS USING DIFFERENTIAL INFRARED THERMOGRAPHY..ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. VOL. 127. ISSUE 8-9. P. 701-705 | 12 | 86% | 2 |
Classes with closest relation at Level 1 |